AUNERIPHARM

Brussel ·KBO/BCE: BE 1002.796.292

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	43.8%	42.2%	better than 52% of 295 sector peers
Net result	€92k	€57k	better than 57% of 294 sector peers
Equity	€157k	€204k	better than 45% of 295 sector peers
Gross operating margin	€342k	€83k	better than 85% of 247 sector peers
Staff costs	€210k	€144k	higher than 56% of 75 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€360k
Fixed assets	21/28	€174
Financial fixed assets	28	€174
Current assets	29/58	€359k
Amounts receivable within one year	40/41	€151k
Cash & bank	54/58	€208k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€360k
Equity	10/15	€157k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€155k
Amounts payable	17/49	€202k
Amounts payable within one year	42/48	€202k
Trade debts payable within one year	44	€18k
Income statement
Gross operating margin	9900	€342k
Operating result	9901	€131k
Financial income	75	€0
Financial charges	65	€5k
Result before taxes	9903	€126k
Income taxes	67/77	€33k
Net result for the period	9904	€92k
Result to be appropriated	9905	€92k

Summary